2007
DOI: 10.1016/j.jinf.2006.06.007
|View full text |Cite
|
Sign up to set email alerts
|

Bone marrow biopsy in the diagnoses of infectious and non-infectious causes in patients with advanced HIV infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
18
1
5

Year Published

2007
2007
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(24 citation statements)
references
References 15 publications
0
18
1
5
Order By: Relevance
“…When comparing these conclusions with earlier similar studies, our diagnostic yield falls within the previously reported ranges of 27-42%. (Engels, Marks & Kazanjian, 1995;Benit, Nunez & De Gorgolas, 1997;Brook et al, 1997;Luther, Lakey & Larson, 2000;Pacios, Alcala & Ruiz-Serrano, 2004;Tanaka et al, 2006). Although our study was performed during the roll-out period of HAART in South Africa, which was initiated in March 2004, only 23% (n = 34) of our cohort were on this therapy.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…When comparing these conclusions with earlier similar studies, our diagnostic yield falls within the previously reported ranges of 27-42%. (Engels, Marks & Kazanjian, 1995;Benit, Nunez & De Gorgolas, 1997;Brook et al, 1997;Luther, Lakey & Larson, 2000;Pacios, Alcala & Ruiz-Serrano, 2004;Tanaka et al, 2006). Although our study was performed during the roll-out period of HAART in South Africa, which was initiated in March 2004, only 23% (n = 34) of our cohort were on this therapy.…”
Section: Discussionmentioning
confidence: 99%
“…A bone marrow biopsy may be a useful analytical tool in some of these patients, with the reported diagnostic yield ranging from 27% to 42% (Engels, Marks & Kazanjian, 1995; Brook et al. , 1997; Luther, Lakey & Larson, 2000; Pacios, Alcala & Ruiz‐Serrano, 2004; Tanaka et al. , 2006).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…8 As the clinical spectrum of this disease has changed, it is appropriate to reevaluate the performance of BMB as a diagnostic tool in the HAART scenario. [9][10][11] The aim of the present study was to compare the diagnostic yield of BMB in HIV infected patients before and after HAART introduction.…”
Section: Introductionmentioning
confidence: 99%
“…Changes in bone marrow morphology associated with HIV-1 infection has been evaluated by various authors 1,5,8,28. These studies showed that certain findings are common to both HIV-1 and MDS.…”
Section: Discussionmentioning
confidence: 99%